{"id":"tetravac-tm","safety":{"commonSideEffects":[{"rate":null,"effect":"Injection site reactions (pain, erythema, swelling)"},{"rate":null,"effect":"Fever"},{"rate":null,"effect":"Myalgia"},{"rate":null,"effect":"Fatigue"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"anthropic-haiku","explanation":"The vaccine formulation combines four separate antigenic components to elicit immune responses against multiple targets in a single administration. This polyvalent approach allows for broader protection and reduced number of injections compared to monovalent vaccines. The specific mechanism depends on the target pathogens, which may include viral or bacterial antigens designed to stimulate both humoral and cellular immunity.","oneSentence":"Tetravac is a tetravalent vaccine that provides immunological protection against four distinct pathogens or disease targets through simultaneous antigenic stimulation.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T01:38:18.233Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Prevention of four vaccine-preventable diseases (specific pathogens not publicly detailed in available sources)"}]},"trialDetails":[{"nctId":"NCT00871000","phase":"PHASE3","title":"Immunogenicity and Safety of Boostrix Polio Vaccine as a Booster Dose in 5 to 6-year-old Children.","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2009-04-01","conditions":"Acellular Pertussis, Tetanus, Diphtheria","enrollment":303}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["DTPa-IPV"],"phase":"phase_3","status":"active","brandName":"Tetravac TM","genericName":"Tetravac TM","companyName":"GlaxoSmithKline","companyId":"glaxosmithkline","modality":"Biologic","firstApprovalDate":"","aiSummary":"Tetravac is a tetravalent vaccine that provides immunological protection against four distinct pathogens or disease targets through simultaneous antigenic stimulation. Used for Prevention of four vaccine-preventable diseases (specific pathogens not publicly detailed in available sources).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":1},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}